体重增加与与性别有关的差异之间的关联通过5-Fluorouracil管理
Masashi Imai1, Keiichi Hiramoto1, Shota Tanaka1
1Department of Pharmaceutical Sciences, Suzuka University of Medical Science.
Biological & pharmaceutical bulletin
|August 28, 2024
概括
5-甲 (5-FU) 通过增加食欲,导致雌性小鼠的体重增加. 这种性别差异与荷尔蒙变化和神经递质变化有关,为化疗副作用提供了洞察力.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
背景情况:
- 越来越多地认识到癌症发病率,生存率和药物疗效方面的性别差异.
- 体重增加是女性乳腺癌患者接受特定化疗方案 (如CMF) 的报告副作用.
- 这些性别特异性化疗效应背后的机制需要进一步研究.
研究的目的:
- 调查5-甲 (5-FU) 在引起体重增加中的作用.
- 为了探索对5-FU管理的反应中与性别相关的差异.
- 在雌性小鼠中阐明5-FU诱导的体重增加的潜在生物机制.
主要方法:
- 用小鼠进行了实验,以评估在5-FU给药后体重变化和食物摄入量.
- 分析包括测量雌性小鼠的诺拉上腺素,上腺素受体表达 (α1和α2), Estradiol 和 ghrelin 的水平.
主要成果:
- 与对照组相比,5-FU的使用导致雌性小鼠显著增加体重和增加食物摄入量.
- 雌性小鼠表现出高上腺素和α1/α2-上腺素受体表达.
- 在接受5 - FU治疗的雌性小鼠中观察到雌激素的降低和林水平的增加.
结论:
- 5-FU的使用导致体重增加的性别差异,主要影响雌性小鼠.
- 增加的食物摄入量,由高上腺素,上腺素受体和 ghrelin 驱动,以及减少的雌激素,有助于 5-FU 诱导的女性体重增加.
- 这些发现为女性乳腺癌患者的化疗相关体重增加提供了机械洞察力.
相关概念视频
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
467
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
467
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
01:22Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K